Importance Estimates of the relative mortality risks associated with normal weight,
overweight, and obesity may help to inform decision making in the clinical setting. Objective …

The first description of patients with clustering of various metabolic abnormalities was as
early as 1923 but it was more than five decades later, in 1988, that Reaven coined the term …

Background Insulin resistance (IR) and the consequences of compensatory
hyperinsulinemia are pathogenic factors for a set of metabolic abnormalities, which …

Background Non‐alcoholic fatty liver disease (NAFLD) encompasses a wide spectrum of
clinical conditions, actually representing an emerging disease of great clinical interest …

Background Liver steatosis is often found in association with common cardiometabolic
disorders, conditions that may all occur in a shared context of abdominal obesity and …

STUDY QUESTION What are the most relevant factors associated with non-alcoholic fatty
liver disease (NAFLD) in women with polycystic ovary syndrome (PCOS)? SUMMARY …

Objective The metabolic syndrome (MS) is a cluster of cardiometabolic factors, which
predisposes to diabetes and cardiovascular disease (CVD). Early detection of high-risk …

Background Lipid accumulation product (LAP) has been advocated as a simple clinical
indicator of metabolic syndrome (MS). However, no studies have evaluated the accuracy of …

Background: The relationship between insulin resistance and hypertension is well
established, but the association of different surrogate insulin resistance indexes with the …

Objectives: Adiposity, defined by higher cardiometabolic index (CMI), lipid accumulation
product (LAP), and body adiposity index (BAI), has conferred increased metabolic risk …